Gynogen HP Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Menotrophin

Indications/Uses

Patient who have received a GnRH agonist for pituitary suppression.

Click to view Gynogen HP detailed prescribing information

Dosage/Direction for Use

IM/SC Patient who have received a GnRH agonist for pituitary suppression Initially 225 IU. Adjust dose not more frequently than once every 2 days & should not exceed 150 IU/adjustment. Max: 450 IU/day & not beyond 20 days.

Click to view Gynogen HP detailed prescribing information

Overdosage

View Gynogen HP overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity. Women w/ high FSH level indicating primary ovarian failure, uncontrolled thyroid & adrenal dysfunction, organic intracranial lesion eg, pituitary tumor, sex hormone dependent tumors of the reproductive tract & accessory organs, abnormal uterine bleeding of undetermined origin, ovarian cysts or enlargement not due to polycystic ovary syndrome. Pregnancy.

Click to view Gynogen HP detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Gynogen HP detailed prescribing information

Special Precautions

Patients w/ tubal obstruction should be treated only if enrolled in an IVF program. Exam carefully to rule out presence of early pregnancy. Patients in late reproductive life; patients who demonstrate abnormal uterine bleeding or other signs of endometrial abnormalities. Evaluate partner's fertility potential. Mild to moderate uncomplicated ovarian enlargement. Lactation. Childn. Elderly.

Click to view Gynogen HP detailed prescribing information

Use In Pregnancy & Lactation

Click to view Gynogen HP detailed prescribing information

Adverse Reactions

Pain/rash at inj site, headache, malaise; nausea, vomiting, abdominal pain, bloating; breast tenderness, hot flushes, OHSS (insusceptible individuals).

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Gynogen HP detailed prescribing information

Storage

View Gynogen HP storage conditions for details to ensure optimal shelf-life.

Description

View Gynogen HP description for details of the chemical structure and excipients (inactive components).

Action

View Gynogen HP mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Trophic Hormones & Related Synthetic Drugs

ATC Classification

G03GA02 - human menopausal gonadotrophin ; Belongs to the class of gonadotropins. Used as ovulation stimulants.

Regulatory Classification

Presentation/Packing

Form

Gynogen HP powd for inj 75 IU

Packing/Price

(+ 1-mL solvent in amp) 1's

Gynogen HP

menotrophin

Manufacturer:

MedEthix

Distributor:

MedEthix